Sickle Cell Disease Assn - FL Miami-Dade, Miami 33136

Sickle Cell Disease Assn entered the industry of Medical Research in 1978 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 8139100, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Astrib Mack, Executive Director by calling (305) 324-6219 during business hours. You can also write to the business’ Single Location at 794 Nw 18th St, Miami, Florida FL 33136. You can also visit the company’s website at sicklecellmiami.org. View this business’ social media profiles on Twitter or on Facebbok .

Company: Sickle Cell Disease Assn
Representative: Astrib Mack, Executive Director
Place of Business: 794 Nw 18th St, Miami, FL 33136
Contact Number: (305) 324-6219
Website: sicklecellmiami.org
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 8139100
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1978
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Sickle Cell Disease Assn is a company operating from Miami-Dade, Florida providing professional Medical Research and relevant B2B variables. It was founded in 1978 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 8139100 as Medical Research.

With a current employee count of 1 to 4, Sickle Cell Disease Assn has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Astrib Mack, Executive Director at (305) 324-6219 for related queries, or to locate its Single Location using the coordinates 25.79224,-80.20876.

The Single Location can also be found at the street address 794 Nw 18th St in Miami, Florida 33136 and can be engaged online through the company website at sicklecellmiami.org, the company Twitter , and Facebook page .